Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Intranasal Migraine Drugs Market

Intranasal migraine drugs Market by Therapeutic Class (Corticosteroids, NSAID’S, Opioids, Antibiotics, Local Anesthesia, and Antihistamines), Indication (Common Migraine, Classic Migraine, Cluster Migraine, and Others), Range (Broad spectrum/ Chronic and Narrow spectrum/ Acute), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Third party manufacturing companies): Global Opportunity Analysis and Industry Forecast, 2021–2030

A12660
Pages: NA
Oct 2021 | 59 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Intranasal Migraine Drugs Market

Request Now !

Intranasal drugs are an important part of migraine treatment. Migraine headache attacks are prevented by using these medicines. It assists in reducing headache pain and other symptoms like sensitivity to sound or light. Timely treatment enables a patient to get back to their normal routine shortly and may lessen your requirement for different pain medications. Migraine occurrences are not be prevented by this medication. New product launches by key manufacturers, rising R&D activities, and quick drug approvals by regulatory bodies such as the U.S. Food and Drug Administration for chronic and acute migraines have anticipated providing profitable opportunities in the coming years.

Market Scope and Structure Analysis

Report Metric

Details

Market Size Available for Years

 2021–2030

  Base Year Considered

   2020

  Forecast Period

  2021–2030

  Forecast Unit

  Value (USD)

  Segments Covered

  Product Type, Application, End User, and Region

Regions Covered

  North America, Europe, Asia-Pacific, and LAMEA

  Companies Covered

Aegis Therapeutics LLC, Neuro Pharma, Rd. Reddy’s Laboratories, Novartis AG, Pfizer Inc., Lockhart ltd, Roche, Sanofi,  Merck, Baxter International Inc., Becton, Dickinson and Company, GlaxoSmithKline PLC, and Johnson & Johnson Inc.

 

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the intranasal migraine drugs market.

Top Impacting Factors

  • Increase in cases of acute migraine and chronic sinusitis, rise in demand for advanced treatments, and surge in healthcare expenditure are factors that drive the growth of the intranasal migraine drugs market.
  • In addition, collaborations, mergers & acquisitions between key players to facilitate drug development; rise in R&D activities to improve quality of drugs; launch of the novel developed drug in market; and technological advancements are some factors, which boost the market growth for intranasal migraine drugs.
  • However, less awareness for the alternative treatment for lung diseases, side effects linked with the drugs such as quick heartbeat, shortness of breath, and more may hinder the intranasal migraine drugs market growth. intranasal migraine drugs market
  • Contrarily, favorable reimbursement policies and support from the government for regulatory approval present new pathways in the industry.

Intranasal migraine drugs Market Trends

New product launches to flourish the market

In January 2021, Impel Neuro Pharma received U.S. Food and Drug Administration (FDA) approval for the new drug application for INP104, for the acute treatment of migraine headaches.

In March 2021, Cipla received U.S FDA approval to treat migraine attacks for a nasal spray.

In June 2020, Tonix Pharmaceuticals acquired pain and non-addictive migraine treatment programs of Trigemina Inc. and will also acquire the license of TNX-1900 intranasal oxytocin. It has the potential to treat craniofacial pain and migraine.

In January 2019, Dr. Reddy's Laboratories received the US Food and Drug Administration (FDA) approval for a sumatriptan nasal splash to provide the intense therapy for headache.

Key Segments Covered

Segment

Subsegment

  Therapeutic Class

  • Corticosteroids
  • NSAID’S
  • Opioids
  • Antibiotics
  • Local Anesthesia
  • Antihistamines

  Indication

  • Common Migraine
  • Classic Migraine
  • Cluster Migraine
  • Others

  Range

  • Broad spectrum/ Chronic
  • Narrow spectrum/ Acute

  Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Third party manufacturing companies

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the intranasal migraine drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the intranasal migraine drugs market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the intranasal migraine drugs market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the intranasal migraine drugs market.
  • The report provides a detailed intranasal migraine drugs market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the intranasal migraine drugs Report

  • Which are the leading players active in the intranasal migraine drugs market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the intranasal migraine drugs market?
  • What future projections would help in taking further strategic steps?
  • What is "Intranasal migraine drugs"?
  • What is "Intranasal migraine drugs” Market prediction in the future?
  • Who are the leading global players in the "Intranasal migraine drugs" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Intranasal migraine drugs” Market report?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Intranasal Migraine Drugs Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers